Summary

Maintaining the insulin dosage when starting sodium-glucose cotransporter-2 inhibitors can be a good practice

Esther Álvarez-Rodríguez1,2 , Marina Gil Mosquera2,3, Pablo Matías Soler2,3

Affiliation of the authors

1Servicio de Urgencias, Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain. 2Grupo de Trabajo SEMES Diabetes, Endocrinología y Metabolismo. 3Servicio de Urgencias, Hospital Universitario Clínico San Carlos, Madrid, Spain.

DOI

Quote

Álvarez-Rodríguez E, Gil Mosquera M, Matías Soler P. Maintaining the insulin dosage when starting sodium-glucose cotransporter-2 inhibitors can be a good practice. Rev Esp Urg Emerg. 2024;3:67–8

More articles by the authors

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.